
StudyFinder
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis

Recruiting
The purpose of this research study is because Cystic Fibrosis Related Diabetes (CFRD) has been identified by the cystic fibrosis (CF) community as one of the top ten priorities for CF research. We know that high blood sugars caused by not enough insulin lead to worse lung function in CF even before diabetes develops. However, we do not know which people with abnormal blood sugars will have long term problems.
All
6 Years to old
Inclusion Criteria:
Age >/= 6 years
Diagnosis of cystic fibrosis
CF patients regularly attending the CF centers
Clinically stable in previous 3wks:
absence of major clinical events including pulmonary exacerbations,
no change in their habitual treatment regimen including introduction of antibiotics or steroids in the past 3 weeks
Exclusion Criteria:
Diagnosis of type 1 diabetes, type 2 diabetes, or MODY
Organ transplantation
new diagnosis of CFRD in the past 6 months
antidiabetic treatment in past 6 mos (insulin or oral hypoglycemic agents)
-patients with previous CFRD diagnosis, but not currently taking insulin/glucose-lowering medications for at least 6 months should be included
pulmonary exacerbation associated with systemic steroid requirement in the last 6 months
on CFTR corrector less than 6 months prior to enrollmentDiagnostic Test: Continuous glucose monitoring, Diagnostic Test: Dexa scan, Diagnostic Test: Oral glucose tolerance test
Cystic Fibrosis-related Diabetes
cystic fibrosis, insulin, glucose, children, abnormal glucose tolerance, impaired glucose tolerance, indeterminate glycemia, diabetes
Amir Moheet - mohee002@umn.edu
Amir Moheet
N/A
STUDY00004854
STUDY00004854
See this study on ClinicalTrials.gov